Search here...
Subscribe

Tag: Mesdopetam

spot_imgspot_img

Ipsen obtains development and commercial rights to mesdopetam

News Swati Rana -
Ipsen and IRLAB have signed a licensing agreement, providing Ipsen exclusive worldwide development and commercial rights to mesdopetam, a novel dopamine D3-receptor antagonist. Mesdopetam is...

Follow us

Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy

Company

Latest news

Thousands of illicit medicines seized in Manchester

News 0
These include powerful opioid painkillers and antidepressants, as well...

Valproate National Patient Safety Alert – GPhC tells what pharmacists need to do

News 0
Pharmacy teams should be prepared to discuss the current...

Cases of norovirus in England almost tripled last week

News 0
The number of norovirus, flu and RSV infections are...

Popular news

EXCLUSIVE – Andrew Lane: Empowering pharmacy contactors

BIG INTERVIEW 0
After two days of intense deliberation on the future...

Pharmacy Business Diversity Conference – session summary: ‘Building environment of trust and comfort is must to tackle mental health issues at workplace’

Conference 0
Mental health has become a major concern worldwide and...

ITV invests in pain relief brand Flarin

News 0
ITV on Tuesday (Aug 15) said it had agreed...

Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc